Prevalence of Intracranial Atherosclerotic Disease in Patients with Low-Risk Transient or Persistent Neurologic Events

References

1. 1.↵
   1. Battistella V,
   2. Elkind M

   . Intracranial atherosclerotic disease. Eur J Neurol 2014;21:956–62 doi:10.1111/ene.12385 pmid:24612339

   CrossRefPubMed
2. 2.↵
   1. Sacco RL,
   2. Kargman DE,
   3. Gu Q, et al

   . Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14–20 doi:10.1161/01.STR.26.1.14 pmid:7839388

   Abstract/FREE Full Text
3. 3.↵
   1. Wong LK

   . Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158–59 doi:10.1111/j.1747-4949.2006.00045.x pmid:18706036

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Suri MFK,
   2. Qiao Y,
   3. Ma X, et al

   . Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population. Stroke 2016;47:1187–93 doi:10.1161/STROKEAHA.115.011292 pmid:27056984

   Abstract/FREE Full Text
5. 5.↵
   1. Hurford R,
   2. Wolters FJ,
   3. Li L, et al

   . Prognosis of asymptomatic intracranial stenosis in patients with transient ischemic attack and minor stroke. JAMA Neurol 2020;77:947–54 doi:10.1001/jamaneurol.2020.1326 pmid:32453401

   CrossRefPubMed
6. 6.↵
   1. Johnston SC,
   2. Easton JD,
   3. Farrant M, et al

   ; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018;379:215–25 doi:10.1056/NEJMoa1800410

   CrossRefPubMed
7. 7.↵
   1. Wang Y,
   2. Wang Y,
   3. Zhao X, et al

   . CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11–9 doi:10.1056/NEJMoa1215340 pmid:23803136

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Hurford R,
   2. Wolters FJ,
   3. Li L, et al

   . Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study. Lancet Neurol 2020;19:413–21 doi:10.1016/S1474-4422(20)30079-X pmid:32333899

   CrossRefPubMed
9. 9.↵
   Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003;22:106–17 doi:10.1159/000068744 pmid:12656117

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Coutts SB,
    2. Moreau F,
    3. Asdaghi N

    , Diagnosis of Uncertain-Origin Benign Transient Neurological Symptoms (DOUBT) Study Group, et al. Rate and prognosis of brain ischemia in patients with lower-risk transient or persistent minor neurologic events. JAMA Neurol 2019;76:1439–45 doi:10.1001/jamaneurol.2019.3063 pmid:31545347

    CrossRefPubMed
11. 11.↵
    The WHO MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105–14 doi:10.1016/0895-4356(88)90084-4 pmid:3335877

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Samuels OB,
    2. Joseph GJ,
    3. Lynn MJ, et al

    . A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46 pmid:10782772

    Abstract/FREE Full Text
13. 13.↵
    1. Barnett HJ,
    2. Warlow CP

    . Carotid endarterectomy and the measurement of stenosis. Stroke 1993;24:1281–84 doi:10.1161/01.STR.24.9.1281 pmid:8362418

    FREE Full Text
14. 14.↵
    1. Redgrave JN,
    2. Coutts SB,
    3. Schulz UG, et al

    . Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007;38:1482–88 doi:10.1161/STROKEAHA.106.477380 pmid:17379821

    Abstract/FREE Full Text
15. 15.↵
    1. Newson RB

    . Attributable and unattributable risks and fractions and other scenario comparisons. The Stata Journal 2013;13:672–98 doi:10.1177/1536867X1301300402

    CrossRef
16. 16.↵
    1. Leng X,
    2. Hurford R,
    3. Feng X, et al

    . Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review. J Neurol Neurosurg Psychiatry 2021 Mar 30 [Epub ahead of print] doi:10.1136/jnnp-2020-325630 pmid:33785575

    Abstract/FREE Full Text
17. 17.
    1. Homburg PJ,
    2. Plas GJ,
    3. Rozie S, et al

    . Prevalence and calcification of intracranial arterial stenotic lesions as assessed with multidetector computed tomography angiography. Stroke 2011;42:1244–50 doi:10.1161/STROKEAHA.110.596254 pmid:21454818

    Abstract/FREE Full Text
18. 18.↵
    1. Ovesen C,
    2. Abild A,
    3. Christensen AF, et al

    . Prevalence and long-term clinical significance of intracranial atherosclerosis after ischaemic stroke or transient ischaemic attack: a cohort study. BMJ Open 2013;3:e003724 doi:10.1136/bmjopen-2013-003724 pmid:24148214

    Abstract/FREE Full Text
19. 19.↵
    1. Banerjee C,
    2. Chimowitz MI

    . Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res 2017;120:502–13 doi:10.1161/CIRCRESAHA.116.308441 pmid:28154100

    Abstract/FREE Full Text
20. 20.↵
    1. Wong KS,
    2. Gao S,
    3. Chan YL, et al

    . Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002;52:74–81 doi:10.1002/ana.10250 pmid:12112050

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Lee DK,
    2. Kim JS,
    3. Kwon SU, et al

    . Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005;36:2583–88 doi:10.1161/01.STR.0000189999.19948.14 pmid:16269637

    Abstract/FREE Full Text
22. 22.↵
    1. Amarenco P,
    2. Denison H,
    3. Evans SR, et al

    ; THALES Steering Committee and Investigators. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke 2020;51:3504–13 doi:10.1161/STROKEAHA.120.032239 pmid:33198608

    CrossRefPubMed
23. 23.↵
    1. Chimowitz MI,
    2. Lynn MJ,
    3. Derdeyn CP

    , et al. SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003 doi:10.1056/NEJMoa1105335 pmid:21899409

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Zaidat OO,
    2. Fitzsimmons BF,
    3. Woodward BK, et al

    ; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 2015;313:1240–48 doi:10.1001/jama.2015.1693 pmid:25803346

    CrossRefPubMed
25. 25.↵
    1. Alexander MJ,
    2. Zauner A,
    3. Chaloupka JC, et al

    ; WEAVE Trial Sites and Interventionalists. WEAVE Trial. Stroke 2019;50:889–94 doi:10.1161/STROKEAHA.118.023996 pmid:31125298

    CrossRefPubMed
26. 26.↵
    1. Alexander MJ,
    2. Zauner A,
    3. Gupta R, et al

    . The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes. J Neurointerv Surg 2021;13:307–10 doi:10.1136/neurintsurg-2020-016208 pmid:32561658

    Abstract/FREE Full Text
27. 27.↵
    1. Coutts SB,
    2. Modi J,
    3. Patel SK, et al

    ; Calgary Stroke Program. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke 2012;43:1013–17 doi:10.1161/STROKEAHA.111.637421 pmid:22302109

    Abstract/FREE Full Text
28. 28.↵
    1. Ssi-Yan-Kai G,
    2. Nasr N,
    3. Faury A, et al

    . Intracranial artery stenosis or occlusion predicts ischemic recurrence after transient ischemic attack. AJNR Am J Neuroradiol 2013;34:185–90 doi:10.3174/ajnr.A3144 pmid:22678847

    Abstract/FREE Full Text